Table 2.
Characteristics of medication recommendations.
| Characteristics | ||
|---|---|---|
| Number of recommendations (n, range) | 111 | 1–12 |
| Number of recommendations per patient (median, IQR) | 5 | 1–8 |
| Drugs | ||
| Antibiotics and antifungal drugs, n, % | 64 | 57.7% |
| Antiviral treatment, n, % | 32 | 28.8% |
| Drugs for digestive symptoms, n, % | 6 | 5.4% |
| Others, n, % | 9 | 8.1% |
| Acceptance | ||
| Recommendations accepted, n, % | 106 | 95.5% |
| Recommendation type | ||
| Treatment effectiveness, n, % | 53 | 47.7% |
| Adverse drug event occurring, n, % | 58 | 52.3% |
| Cause for recommendation | ||
| Drug selection, n, % | 79 | 71.2% |
| Dose selection, n, % | 20 | 18.0% |
| Treatment duration, n, % | 12 | 10.8% |
| Recommendations at drug level | ||
| Drug discontinuation, n, % | 35 | 31.5% |
| Switched to other drugs, n, % | 27 | 24.3% |
| Adding a new drug, n, % | 22 | 19.8% |
| Dose adjustment, n, % | 17 | 15.3% |
| Suspected ADR monitoring, n, % | 9 | 8.1% |
| Drug concentration monitoring, n, % | 1 | 0.9% |
ADR: adverse drug reactions.